Loading...
Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519
Saved in:
| Published in: | Front Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280745/ https://ncbi.nlm.nih.gov/pubmed/32581793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|